A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test that shows how blood flows to tissues and organs. Nuclear imaging requires small amounts of radioactive materials called radiopharmaceuticals – injected, inhaled or swallowed – to diagnose disease. SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, In-111，and other SPECT isotopes.
This report contains market size and forecasts of SPECT Radiopharmaceuticals in global, including the following market information:
Global SPECT Radiopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global SPECT Radiopharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five SPECT Radiopharmaceuticals companies in 2021 (%)
The global SPECT Radiopharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Technetium-99 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of SPECT Radiopharmaceuticals include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Eczacibasi-Monrol Nuclear Products, IBA Molecular Imaging and Jubilant Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the SPECT Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global SPECT Radiopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global SPECT Radiopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other
Global SPECT Radiopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global SPECT Radiopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Oncology
Cardiology
Thyroid
Global SPECT Radiopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global SPECT Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies SPECT Radiopharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies SPECT Radiopharmaceuticals revenues share in global market, 2021 (%)
Key companies SPECT Radiopharmaceuticals sales in global market, 2017-2022 (Estimated), (K Units)
Key companies SPECT Radiopharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences